pregnant woman.jpg
world-centralasia.jpg

We push the boundaries of molecular diagnostics through quantitative technologies.


SCROLL DOWN

We push the boundaries of molecular diagnostics through quantitative technologies.


BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.

pregnant woman.jpg

Making single-gene NIPT accessible to all


Making single-gene NIPT accessible to all


Available in June 2019

The First and Only Carrier Screen with Reflex Single-gene NIPT

Our first commercial product, UNITY, is the single-gene NIPT supported carrier screen for cystic fibrosis, spinal muscular atrophy, sickle cell disease, and alpha- and beta-thalassemia. Visit our product site to learn more.

 

 

world-centralasia.jpg

Join us in our journey to transform molecular diagnostics.


Join us in our journey to transform molecular diagnostics.